SBH Sally Beauty Holdings, Inc.
Retail-Retail Stores, NEC · NYSE · SEC CIK 1368458 · Fiscal year ends 09/30
Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY2.1%
TTM EPS YoY6.9%
Revenue 3-yr CAGR0.1%
Net income 3-yr CAGR2.7%
Margins
Gross margin52.0%
Operating margin8.7%
Net margin5.4%
FCF margin5.6%
EBITDA margin11.4%
Returns
ROE23.8%
ROA6.9%
ROIC (approx.)16.0%
Asset turnover1.29x
Leverage & solvency
Liabilities / assets69.4%
Debt / equity0.89x
Current ratio2.37x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.61x
Accruals ratio-4.2%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-09-30 | FY20252025-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $3.73B | $3.70B |
| Cost of revenue | $1.79B | $1.79B |
| Gross profit | $1.94B | $1.91B |
| SG&A expense | $1.62B | $1.58B |
| Operating income | $326.45M | $327.81M |
| Interest expense | — | $64.39M |
| Pretax income | $270.10M | $263.42M |
| Income tax | $70.02M | $67.54M |
| Net income | $200.08M | $195.88M |
| EBITDA | $427.31M | $427.73M |
| EPS (basic) | 2.09 | 1.95 |
| EPS (diluted) | 2.02 | 1.89 |
| Weighted avg. shares (diluted) | 98.81M | 103.82M |
| Balance sheet | ||
| Cash & equivalents | $158.16M | $149.16M |
| Receivables | $30.09M | $31.83M |
| Inventory | $1.00B | $987.58M |
| Current assets | $1.30B | $1.30B |
| PP&E, net | $285.02M | $284.28M |
| Goodwill | $537.98M | $540.67M |
| Intangibles | $50.04M | $53.02M |
| Total assets | $2.90B | $2.87B |
| Current liabilities | $550.25M | $575.97M |
| Short-term debt | $4.00M | $4.00M |
| Long-term debt | $784.04M | $861.97M |
| Total debt | $788.04M | $865.97M |
| Total liabilities | $2.01B | $2.08B |
| Shareholders' equity | $889.01M | $794.21M |
| Net debt | $629.88M | $716.81M |
| Shares outstanding | 91.52M | 97.88M |
| Cash flow statement | ||
| Operating cash flow | $322.56M | $274.83M |
| Capital expenditure | $112.44M | $102.14M |
| Free cash flow | $210.11M | $172.69M |
| Investing cash flow | -$112.44M | -$58.28M |
| Financing cash flow | -$200.36M | -$178.42M |
| Depreciation & amortization | $100.86M | $99.92M |
| Stock-based compensation | $23.57M | $19.25M |
| Share buybacks | $113.86M | $54.00M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.